Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Nasser, Altorki"'
Autor:
Enriqueta Felip, Hiroshi Tanaka, Silvia Novello, Hao Xu, Heather Wakelee, Barbara Gitlitz, Martin Reck, Wei Zou, Elizabeth Bennett, Mark McCleland, Caicun Zhou, Satoshi Oizumi, Anna Kryzhanivska, Virginia McNally, Marcus Ballinger, Meghna Das Thakur, Steven L McCune, John Hamm, Minu K Srivastava, Nasser Altorki, Rüdiger Liersch
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background Tumor samples from the phase III IMpower010 study were used to compare two programmed death-ligand 1 (PD-L1) immunohistochemistry assays (VENTANA SP263 and Dako 22C3) for identification of PD-L1 patient subgroups (negative, positive, low,
Externí odkaz:
https://doaj.org/article/cfe63add9cfe46b48a019fc54672b05f
Autor:
Benjamin E. Lee, Nasser Altorki
Publikováno v:
Cancers, Vol 15, Iss 11, p 2914 (2023)
The Lung Cancer Study Group previously established lobectomy as the standard of care for treatment of clinical T1N0 NSCLC. Advances in imaging technology and refinements in staging have prompted a re-investigation to determine the non-inferiority of
Externí odkaz:
https://doaj.org/article/b142138e0aaf4c54a31327045a7a3af8
Publikováno v:
Nature Reviews Clinical Oncology. 20:390-407
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 165:495-499
Autor:
Jessica S, Donington, Barbara, Gitlitz, Eric, Lim, Isabelle, Opitz, Young Tae, Kim, Nasser, Altorki
This review describes a new therapeutic landscape in the adjuvant treatment of resectable non-small cell lung cancer (NSCLC) and discusses the role of the surgeon in ensuring the best outcomes within this treatment paradigm.We conducted a narrative l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29cbf7a752f4a0f2a56a4672f8be2f27
https://doi.org/10.5167/uzh-228736
https://doi.org/10.5167/uzh-228736
Autor:
Jack Wish, Jonathan Villena-Vargas, Sebron Harrison, Ben Lee, Oliver Chow, Jeffrey Port, Nasser Altorki, Brendon M. Stiles
Publikováno v:
World Journal of Surgery.
Autor:
Joseph M. Scandura, Pouneh Kermani, Agnes Viale, Daoqi You, Romae Palmer, Paul J. Christos, Rhonda Yantiss, Andrew Schreiner, Michael Lieberman, Nasser Altorki, Elizabeta Popa, Allyson Ocean, Kelsey Klute, Manish A. Shah, Bryan J. Schneider
Treatment Exposure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756e39fb3cec3588b8c150cdd561f3ed
https://doi.org/10.1158/1078-0432.22462362
https://doi.org/10.1158/1078-0432.22462362
Autor:
Joseph M. Scandura, Pouneh Kermani, Agnes Viale, Daoqi You, Romae Palmer, Paul J. Christos, Rhonda Yantiss, Andrew Schreiner, Michael Lieberman, Nasser Altorki, Elizabeta Popa, Allyson Ocean, Kelsey Klute, Manish A. Shah, Bryan J. Schneider
EOX Dose Modifications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658d2fd97b12ffdbbdb2951fa3ebe9f4
https://doi.org/10.1158/1078-0432.22462365.v1
https://doi.org/10.1158/1078-0432.22462365.v1
Autor:
Joseph M. Scandura, Pouneh Kermani, Agnes Viale, Daoqi You, Romae Palmer, Paul J. Christos, Rhonda Yantiss, Andrew Schreiner, Michael Lieberman, Nasser Altorki, Elizabeta Popa, Allyson Ocean, Kelsey Klute, Manish A. Shah, Bryan J. Schneider
Purpose: Epigenetic silencing of tumor suppressor genes (TSG) is an acquired abnormality observed in cancer and is prototypically linked to DNA methylation. We postulated that pretreatment (priming) with 5-azacitidine would increase the efficacy of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3993dd79de54ef537605ead8625d2d1b
https://doi.org/10.1158/1078-0432.c.6525087
https://doi.org/10.1158/1078-0432.c.6525087
Autor:
Geoffrey Markowitz, Yi Ban, Michael Crowley, Diamile Tavarez, Stephen T.C. Wong, Kenneth Chang, Andrea Schietinger, Nasser Altorki, Vivek Mittal
Publikováno v:
Journal of Clinical and Translational Science, Vol 5, Pp 89-89 (2021)
ABSTRACT IMPACT: T cell dysfunction is a dominant suppressor of anti-tumor immunity, reducing immunotherapeutic efficacy and benefit to patients; our work will identify novel mediators of this process for both therapeutic potential and underlying mec
Externí odkaz:
https://doaj.org/article/c72715e16422418d845d7d02faa8b3f7